
SCARBOROUGH — Oncologist Dr. Dan Rausch has begun seeing patients in Scarborough with New England Cancer Specialists (NECS).
NECS is a regional oncology group with 13 physicians and 23 advanced practice providers serving Maine and New Hampshire. The group is the first Affiliate Member of the Dana-Farber Cancer Institute in Boston. NECS has offices in Scarborough, Topsham, and Kennebunk in Maine, and Portsmouth in New Hampshire.
Rausch, from Auburn, has joined the team and will practice at the Scarborough office.
“I am excited about the opportunity to join the team here in providing top-tier care to Mainers who are facing a cancer diagnosis,” Rausch said.
Rausch was born in Lewiston and grew up in Auburn, where he still lives. He graduated from Haverford College in Philadelphia and went to medical school at Tufts University. Rausch finished his residency at Lahey Clinic Medical Center in Burlington, Massachusetts, and did a fellowship at St. Elizabeth’s Medical Center. He is board-certified in hematology and oncology.
“We are so happy to welcome Dr. Rausch to our New England Cancer Specialists family,” said NECS President and lead physician Dr. Chiara Battelli. “Dr. Rausch has extensive experience and a wonderful reputation. He also shares our commitment to caring for each patient as a whole person.”
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less